News
Second quarter revenue increased 14% year-over-year to $45.5 millionCommercial Cell & Gene Therapy revenue increased 33% year ...
Abeona Therapeutics Inc. (NASDAQ:ABEO) is one of the stocks under $10 to buy now. On July 29, AscellaHealth announced its ...
Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.
Food dyes are known to have a wide range of impacts on health, such as cancer risks, behavioral problems in children, and disruption to hormones.
The Food & Drug Administration is investigating the death of an 8‑year‑old following Elevidys gene therapy for Duchenne muscular dystrophy. U.S. distribution has been paused amid safety concerns.
The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who received Sarepta Therapeutics' muscular disorder gene therapy Elevidys.
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.
The 2nd annual Red Cross Blood Drive happened on Friday, July 25. The event celebrated the second anniversary of the FDA allowing gay and bisexual men to donate ...
FDA's Makary commits to reviewing abortion pill mifepristone safety data while listening to concerns, stating he has no plans for policy changes.
EsoGuard, a new FDA-approved, minimally invasive test, is helping firefighters detect esophageal cancer early. And it only takes 90 seconds.
Food and Drug Administration (FDA) Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding the abortion drug, mifepristone ...
Mike Pence's think tank is asking the Food and Drug Administration to turn over documents related to the dangers of the abortion pill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results